Decreased perifoveal ganglion cell complex thickness - a first sign for macular damage in patients using hydroxychloroquine
romanian journal of ophthalmology · 2023
DOI: 10.22336/rjo.2023.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift romanian journal of ophthalmology, 2023. Verfasst von Sümeyye Burcu Elpeze Agcayazi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Istanbul Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hydroxychloroquine, Retinal Ganglion Cells, Nerve Fibers, Retinal Diseases. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, Istanbul Training and Research Hospital, Istanbul, Turkey.
- Ophthalmology Department, Ekol Hospital, Edirne, Turkey.
- Ophthalmology Department, Trakya University Faculty of Medicine, Education and Research Hospital, Edirne, Turkey.
Zitieren
APA
Agcayazi, S. B. E., Gurlu, V., & Alacamli, G. (2023). Decreased perifoveal ganglion cell complex thickness - a first sign for macular damage in patients using hydroxychloroquine. romanian journal of ophthalmology. https://doi.org/10.22336/rjo.2023.26
Vancouver
Agcayazi SBE, Gurlu V, Alacamli G. Decreased perifoveal ganglion cell complex thickness - a first sign for macular damage in patients using hydroxychloroquine. romanian journal of ophthalmology. 2023. doi:10.22336/rjo.2023.26
BibTeX
@article{Agcayazi2023,
author = {Agcayazi, Sümeyye Burcu Elpeze and Gurlu, Vuslat and Alacamli, Goksu},
title = {Decreased perifoveal ganglion cell complex thickness - a first sign for macular damage in patients using hydroxychloroquine},
journal = {romanian journal of ophthalmology},
year = {2023},
doi = {10.22336/rjo.2023.26}
}
EUVIMED